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Abstract We examined whether long QT syndrome (LQTS)
mutation carrier status or symptomatic LQTS are associated
with depression, and whether there are sex differences in these
potential relationships. The sample comprised 782 partici-
pants (252 men). Of the 369 genetically defined LQTS muta-
tion carriers, 169 were symptomatic and 200 were asymptom-
atic. The control group consisted of 413 unaffected relatives.
Depression was assessed using the Beck Depression
Inventory-II (BDI-II). No association was found for LQTS
mutation carrier status with depression. The multinomial lo-
gistic regression showed that LQTSmutation carrier men with
arrhythmic events scored higher on depression compared with
the control group, even when adjusting for age, β-blockers,
antidepressants, and social support (OR = 1.09, 95%CI [1.02,
1.15], p = .007). The binary logistic regression comparing
symptomatic and asymptomatic LQTS mutation carriers
showed that symptomatic LQTS was associated with depres-
sion in men (OR = 1.10, 95 % CI [1.03, 1.19], p = .009). The
results were unchanged when additionally adjusted for educa-
tion. These findings suggest that symptomatic LQTS is
associated with depression in men but not in women.
Overall, however, depression is more frequent in women
than men. Thus, regular screening for depression in
LQTS mutation carriers and their unaffected family
members can be important.
Keywords Arrhythmia . Depression . LongQTsyndrome
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Introduction
Long QTsyndrome (LQTS) is a genetic cardiac disorder char-
acterized by delayed ventricular repolarization leading to QT-
interval prolongation observed by electrocardiogram (ECG)
and an increased vulnerability to arrhythmic events, such as
ventricular arrhythmias and sudden cardiac death (Schwartz
et al. 1975). Genetic defects in cardiac ion-channel proteins
are the fundamental cause of the syndrome. According to a
gene possessing mutations, LQTS has been classified into
subtypes, of which LQT1, LQT2, and LQT3 are the most
common. The first two types result from changes in the potas-
sium channel genes KCNQ1 and KCNH2 (HERG), respec-
tively, while LQT3 is caused by mutations in the gene
SCN5A, encoding the sodium channel (Giudicessi and
Ackerman 2013b). The estimated prevalence of this disorder
in Finland is 1:250 (Marjamaa et al. 2009), whereas in other
populations it is reported to be 1:2000 (Schwartz et al. 2009).
A considerable proportion of the Finnish population can be
genetically predisposed to ventricular arrhythmias due to four
LQTS founder mutations, KCNQ1 G589D, KCNQ1 IVS7-
2 A > G (c.1129-2 A > G), KCNH2 L552S, and KCNH2
R176W, that have become enriched in this isolated population
(Marjamaa et al. 2009).
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LQTS penetrance, that is, the percentage of individuals with
a particular mutation who manifest clinical signs of the disor-
der, ranges from 25 % (Priori et al. 1999) to 100 % (Viadero
et al. 2011) among members of the same family. Furthermore,
the syndrome exhibits variable expressivity, which means that
the type and severity of arrhythmic events (i.e., symptoms) can
vary between individuals carrying the same mutation (Brink
et al. 2005). While genetic determinants underlying incomplete
penetrance and variable expressivity remain unclear
(Giudicessi and Ackerman 2013a), some demographic factors,
for instance, male sex in younger patients and female sex in
adult patients, have been suggested to be associated with the
arrhythmic risk in LQTS (Locati et al. 1998).
Arrhythmic events in LQTS tend to occur under specific
conditions in a gene-specific manner (Schwartz et al. 2001). In
LQT1, cardiac events are associated particularly with physical
activity, while in LQT2, sudden emotional stress (stressful life
events or startling auditory stimuli) is a main trigger of ar-
rhythmias. In LQT3, most of the events occur during rest or
sleep (Schwartz et al. 2001). The greater probability of
experiencing symptoms under one condition does not, how-
ever, exclude the possibility of having cardiac events under
other circumstances (Schwartz et al. 2001).
Previous research (Burgess et al. 2005; Ciesla and Roberts
2001; Dickens et al. 2002; Dickens et al. 2004) has repeatedly
documented that serious physical illness may increase the risk
of mental health problems, including depression. Carrying a
LQTS-causing mutation can elicit psychological distress (van
Langen et al. 2004) that has been associated with depression
(Hammen et al. 2009). LQTSmutation carriers have also been
shown to have higher temperamental stress proneness
(Määttänen et al. 2011, 2013b). Being genetically diagnosed
as a LQTSmutation carrier may be associated with depression
because mutation carriers can be worried and stressed about
the risk of potentially lethal cardiac events (Farnsworth et al.
2006) and/or about the possibility of having passed the muta-
tion to their children (van Langen et al. 2004), or may expe-
rience fatigue due to a lower level of physical activity (Berlin
et al. 2006) caused by appropriate lifestyle modifications (e.g.,
avoidance of participation in competitive sports) related to this
syndrome (Priori et al. 2013).
LQTS mutation carriers who have experienced cardiac
events (reminding them of the actual risk of death) have been
shown to be more stressed than mutation carriers without
symptoms (Hintsa et al. 2010). They have also reported peri-
odic feelings of extreme fatigue and exhaustion related to the
syndrome itself (Andersen et al. 2008). Thus, it is reasonable
to assume that mutation carriers with arrhythmias are at a
higher risk of depression compared with those without cardiac
events. Our previous study (Hintsa et al. 2009) has shown that
depressive symptoms (i.e., a lenient tendency for depressive
mood) are associated with symptomatic LQTS independently
of sex and age. This study, however, did not include
dimensions of depression and a measure to screen for depres-
sive disorder, and did not control for social support, medica-
tions (β-blockers and antidepressants), and education. When
studying depression, social support needs to be taken into
account since it has been linked to depression (Huffman
et al. 2013; Paykel 1994). Furthermore, social support has
been suggested as protecting against pathogenic effects of
stressful life events (Paykel 1994). Previous research (Hintsa
et al. 2016) has reported that encountering stressful life events
is associated with an increased risk of depressive mood in
LQTS mutation carriers with arrhythmic events.
Generally, the association between depression and cardio-
vascular disease has been shown to be stronger in women and
women diagnosed with this illness have scored higher on de-
pression compared with men (Moller-Leimkuhler 2007). The
prevalence of major depression is also two-times greater in
female than male coronary artery disease patients
(Shanmugasegaram et al. 2012). Therefore, sex differences
in the potential associations of LQTS mutation carrier status
or symptomatic LQTS with depression can be assumed.
Moreover, because younger age, low education (Huffman
et al. 2013), andβ-blockers (Verbeek et al. 2011) may increase
the risk of depression, their influence on the hypothesized
relationships can also be expected.
The objective of this study was to examine whether LQTS
mutation carrier status or symptomatic LQTS are associated
with an increased risk of depression or any of its dimensions
(affective, cognitive, and somatic), and whether there are sex
differences in these potential relationships.
Methods
Participants and Procedures
Participants were recruited from the Finnish LQTS registry
consisting of individuals from whole Finland who have been
referred for genetic testing for LQTS since 1993. Direct DNA
sequencing and restriction enzyme assays were used to iden-
tify LQTS mutations as previously described (Fodstad et al.
2004, 2006). Registry members fulfilling the following
criteria were included in psychological evaluation: a molecu-
larly verified or excluded familial LQTSmutation, age greater
than or equal to 18, permanent residency in Finland, and a
written informed consent. The classification of the mutations
was performed according to Richards et al. (2015) using in-
formation obtained from the following databases:
SISu (http://www.sisuproject.fi/),









HGMD (Stenson et al. 2003).
Pathogenic and likely pathogenic mutations, and variants of
unknown significance were included in the study, while be-
nign and likely benign variants were excluded. SCN5A
R104Q and SCN5A E1784K mutations were excluded due
to being associated with both LQTS and Brugada syndrome
(Moric et al. 2003). The genetic test results were reviewed in
2016. The study was approved by the Helsinki University
Central Hospital (April 6, 2011).
In 2011, psychological study questionnaires were sent to
1443 individuals who had participated in the previous data
collection phase in 2006. There were 1081 (74.9 %) people
who responded. Of them, 254 (23.5 %) individuals had some
missing information on the study variables and 45 (4.2 %)
individuals were excluded due to redefinition of age criteria
(age ≤ 75). Thus, the final sample comprised 782 participants
(252 men). There were 369 LQTS mutation carriers (113
men). The control group consisted of 413 relatives (139
men) not carrying a familial LQTS-causing mutation. There
were 263 KCNQ1, 87 KCNH2, 12 SCN5A, and six KCNJ2
(Andersen-Tawil syndrome) mutation carriers. One partici-
pant was a carrier of both KCNQ1 and KCNH2 mutations.
Instrumentation
Information regarding the history of arrhythmic events was col-
lected with a questionnaire when a person was entered into the
LQTS registry. The data were updated in 2011 when the present
study was carried out. Those LQTS mutation carriers who had
experienced a documented LQTS-type syncopal episode and/or
aborted cardiac arrest were grouped as symptomatic and those
without the symptoms as asymptomatic LQTSmutation carriers.
Depression was assessed using the 21-item Beck
Depression Inventory-II (BDI-II) (Beck et al. 1996) designed
to screen for depressive disorder based on criteria from the
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV). The participants were asked to de-
scribe how they have been feeling during the past 2 weeks.
Each item had four alternative statements (except for items
concerning change in sleeping and eating habits with seven
statements in order to better evaluate the decrease or increase
in these items). The total possible score for depression ranged
from 0 to 63 (0–3 points for each item). Reliability of the scale
was high (Cronbach’sα = .92).We calculated the sum score of
responses and additionally categorized the participants into
two groups according to whether they screened positively or
negatively for depressive disorder in order to find out the
prevalence of depressive disorder (from mild to severe) in
the sample. The cut-off score of 14 points was used as briefed
in the manual (Beck et al. 1996). The three dimensions of
depression were based on the three-factor model of the BDI-II
(Beck et al. 2002). The affective dimension consisted of five
items (1, 2, 4, 9, and 12), the cognitive dimension was defined
by seven items (3, 5–8, 13, and 14), and the somatic dimension
consisted of nine items (10, 11, and 15–21). Each of the sub-
scales showed high reliability (affective dimension Cronbach’s
α = .80, cognitive dimension Cronbach’s α = .87, and somatic
dimension Cronbach’s α = .82).
Perceived social support was self-rated with the
Multidimensional Scale of Perceived Social Support (MSPSS)
(Zimet et al. 1988) that consists of 12 items such as: There is a
special person who is around when I am in need, I get the
emotional help and support I need from my family, I can count
on my friends when things go wrong. The participants were
asked to rate how well each statement describes them. A 5-
point response scale (ranging from 1 = strongly disagree to
5 = strongly agree) was used instead of the original 7-point
scale. The questionnaire reliability was .96 (Cronbach’s α).
The mean value of responses was calculated.
The participants reported their education as completed de-
grees. We classified them into two groups: lower (basic/voca-
tional education including degrees from a university of applied
sciences) and higher (university degree) education levels.
Data Analysis
First, the association between LQTS mutation carrier status and
depression (linear variable) was tested by conducting binary
logistic regression (comparing LQTS mutation carriers with
the control group). Then, the association between symptomatic
LQTS and depression (linear variable) was examined by mul-
tinomial (comparing symptomatic and asymptomatic LQTS
mutation carriers with the control group) and binary (comparing
symptomatic LQTS mutation carriers with asymptomatic
LQTS mutation carriers) logistic regression analyses. The asso-
ciations were tested controlling for age, β-blockers, antidepres-
sants, social support, and education. The analyses were per-
formed separately for women and men as a marginally signifi-
cant interaction effect of LQTS mutation carrier status and sex
on depression was found (p = .059) in the analysis of variance
(two-way ANOVA). The differences between women and men
in the study variables were tested with a chi-square test, a t-test,
and a one-way ANOVA. The attrition analysis was carried out
with a t-test. All the statistical analyses were conducted using
PASW 18.0.2. software.
Results
The individuals included in the present study (n = 782) were
younger compared with the 254 persons lost due to attrition
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(49.40 vs. 54.86, p < .001). The groups did not differ in social
support or depression (ps > .05).
The characteristics of the final sample by sex are summa-
rized in Table 1. Of the 256 LQTS mutation carrier women,
131 (51.2 %) had experienced an arrhythmic event at least
once in a lifetime. Of the 113 LQTS mutation carrier men,
38 (33.6 %) had had arrhythmic events. More women than
men had experienced arrhythmic events (p = .002). Men were
older than women (51.08 vs. 48.61, p = .024). Women scored
higher on depression (7.01 vs. 4.73, p < .001) compared with
men. More women than men screened positively for depres-
sive disorder (15.8 % vs. 9.1 %, p = .011).
We additionally compared women and men according to
LQTS symptom status group. In the symptomatic LQTS group,
women and men differed in β-blocker treatment (71.8 % vs.
39.5 %, p < .001). In the asymptomatic LQTS group, women
scored higher than men on depression (6.67 vs. 3.92, p = .008)
and its cognitive (1.74 vs. 0.96, p = .042) and somatic dimension
(3.86 vs. 2.28, p = .002). In the control group, women scored
higher on depression (7.18 vs. 4.37, p < .001) and its affective
(1.31 vs. 0.88, p = .019), cognitive (1.78 vs. 1.14, p = .020), and
somatic dimension (4.08 vs. 2.35, p < .001) comparedwithmen.
Women from the control group also reported higher social
support (3.97 vs. 3.68, p = .002) and education level (29.1 %
vs. 18.5 %, p = .040), and were more often users of antidepres-
sants (8.4 % vs. 2.2 %, p = .014) than men.
No association was found for LQTS mutation carrier status
with depression (tested using binary logistic regression) when
comparing LQTSmutation carriers with the control group and
adjusting for age, β-blockers, antidepressants, and social sup-
port (women: OR = 1.00, 95 % CI [0.97, 1.03], p = .93,
R2 = 23.3 %; men: OR = 1.03, 95 % CI [0.98, 1.08],
p = .25, R2 = 11.1 %). Similarly, there were no associations
between LQTS mutation carrier status and any of the dimen-
sions of depression in either women or men (ps > .05). We
additionally adjusted the associations for education (the anal-
ysis had to be carried out on a smaller sample because of
missing information on education for 186 participants [398
women and 198 men]), but this had no effect on any of the
associations (ps > .05).
Table 2 presents the results of the multinomial logistic re-
gression in which LQTS mutation carriers with arrhythmic
events and LQTS mutation carriers without arrhythmic events
were compared with the control group. Symptomatic LQTS
was associated with depression in men independently of age,
β-blocker treatment, antidepressant use, and social support
Table 1 The characteristics of
the study sample by sex Study variables Women(n = 530) Men(n = 252)
Mean/number SD/% Range Mean/ number SD/% Range p-value
Age (years) 48.61 14.86 19–75 51.08 13.99 19–75 .024
Medication
β-blockers 174 32.8 47 18.7 < .001
Antidepressants 45 8.5 12 4.8 .061
Social support 4.09 0.88 1–5 3.81 0.98 1–5 < .001
Depressive disorder .011
Yes 84 15.8 23 9.1
No 446 84.2 229 90.9
Depression (linear) 7.01 7.37 0–38 4.73 6.42 0–55 < .001
Affective dimension 1.21 1.84 0–12 0.90 1.68 0–12 .020
Cognitive dimension 1.84 2.75 0–15 1.24 2.31 0–21 .002
Somatic dimension 3.95 3.60 0–17 2.58 3.10 0–22 < .001
Group status
LQTS mutation carrier
Status 256 48.3 113 44.9
Symptomatic LQTS 131 24.7 38 15.1
Asymptomatic LQTS 125 23.6 75 29.8 .002a
Control group 274 51.7 139 55.2
Educationb .15
Lower 281 70.6 151 76.3
Higher 117 29.4 47 23.7
Abbreviations: LQTS, long QT syndrome; n, number of participants; SD, standard deviation
a Chi-square test comparing proportions of women and men in symptomatic and asymptomatic LQTS status group
bWomen n = 398, men n = 198
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(OR = 1.09, 95 % CI [1.02, 1.15], p = .007, R2 = 15.1 %).
Controlling additionally for education did not change the re-
sults (OR = 1.09, 95%CI [1.02, 1.16], p = .008, R2 = 20.1 %).
No associations were found in women (ps > .05).
We also conducted a multinomial logistic regression anal-
ysis for the three dimensions of depression. There were asso-
ciations of symptomatic LQTS with the cognitive (OR = 1.22,
95 % CI [1.04, 1.42], p = .013, R2 = 14.4 %) and the somatic
dimension (OR = 1.19, 95 % CI [1.05, 1.34], p = .005,
R2 = 14.8 %) in men when controlling for age, β-blockers,
antidepressants, and social support, while the association with
the affective dimension was marginally significant
(OR = 1.23, 95 % CI [1.00, 1.52], p = .054, R2 = 13.5 %).
After adjustment additionally for education, the associations
of symptomatic LQTSwith the cognitive (OR = 1.24, 95%CI
[1.05, 1.47], p = .011, R2 = 19.6%) and the somatic dimension
(OR = 1.20, 95 % CI [1.05, 1.37], p = .006, R2 = 20.3 %)
remained significant, whereas the association with the affec-
tive dimension continued to be marginally significant
(OR = 1.24, 95 % CI [0.99, 1.54], p = .061, R2 = 16.9 %).
In the binary logistic regression comparing LQTSmutation
carriers with and without arrhythmic events, symptomatic
LQTS was associated with depression in men after adjusting
for age, β-blockers, antidepressive medication, and social
support (OR = 1.10, 95 % CI [1.03, 1.19], p = .009,
R2 = 16.0 %) (Table 3). The results remained significant when
we repeated the analysis controlling additionally for education
(OR = 1.14, 95 % CI [1.03, 1.25], p = .011, R2 = 23.7 %). The
association between symptomatic LQTS and depression was
not found in women (ps > .05).
The binary logistic regression analysis performed with the
three dimensions of depression showed that symptomatic
LQTS was associated with the affective (OR = 1.41, 95 %
CI [1.07, 1.87], p = .017, R2 = 13.7 %), the cognitive
(OR = 1.28, 95 % CI [1.04, 1.56], p = .020, R2 = 14.1 %),
and the somatic dimension (OR = 1.19, 95 % CI [1.04, 1.36],
p = .009, R2 = 14.5 %) in men independently of age, β-
blockers, antidepressants, and social support. When control-
ling additionally for education, the associations of symptom-
atic LQTS with the cognitive (OR = 1.37, 95 % CI [1.03,
1.83], p = .032, R2 = 21.3 %) and the somatic dimension
(OR = 1.29, 95 % CI [1.08, 1.54], p = .005, R2 = 24.6 %)
remained significant, but the association with the affective
dimension was attenuated to marginally significant
(OR = 1.31, 95 % CI [0.97, 1.76], p = .080, R2 = 16.4 %).
Discussion
We examined whether LQTS mutation carrier status or symp-
tomatic LQTS are associated with an increased risk of depres-
sion or its three dimensions (affective, cognitive, and somat-
ic), and whether there are sex differences in these relation-
ships. The results showed no associations between being a
LQTS mutation carrier and depression or any of its three di-
mensions. Symptomatic LQTS was associated with depres-
sion in men independently of age, β-blocker and antidepres-
sant treatment, social support, and education. Women scored
higher on depression and all its dimensions compared with
men. Also, more women than men screened positively for
depressive disorder and had experienced cardiac events.
Nevertheless, there were no associations of symptomatic
LQTS with either depression or any of the three dimensions
of depression in women.
Carrying a LQTS-causing mutation and thus being at risk
of potentially fatal arrhythmias was not associated with de-
pression. This is in line with our previous study (Hintsa
et al. 2009) in which no association is evident between being
Table 2 The results of multinomial logistic regression examining the association between lqts symptom status and depression
Group status Women(n = 530) Men(n = 252)
n OR (95 % CI) p-value R2 (%) n OR (95 % CI) p-value R2 (%)
Model 1 0.1 3.5
Control group 274 1.00 139 1.00
Asymptomatic LQTS 125 0.99 (0.96, 1.02) .53 75 0.98 (0.93, 1.04) .56
Symptomatic LQTS 131 1.00 (0.97, 1.03) .80 38 1.06 (1.01, 1.11) .020
Model 2 27.3 15.1
Control group 274 1.00 139 1.00
Asymptomatic LQTS 125 1.01 (0.97, 1.04) .79 75 0.99 (0.93, 1.05) .67
Symptomatic LQTS 131 1.00 (0.96, 1.04) .85 38 1.09 (1.02, 1.15) .007
Abbreviations: CI, confidence interval; n, number of participants; OR, odds ratio; R2 (Nagelkerke), fraction of explained variance
Reference group = control group
Model 1 unadjusted
Model 2 adjusted for age, β-blockers, antidepressants, and social support
Values of the coefficients in bold indicate statistical significance
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aware of LQTS mutation carrier status and an increased vul-
nerability to depressive symptoms. It has been suggested
(Hendriks et al. 2008) that it is not knowledge of the disorder,
but rather uncertainty related to the LQTS diagnosis that leads
to a tendency for depressive mood, at least in the short term.
Our study showed that symptomatic LQTS may increase the
risk of depression in men. We also found that symptomatic
LQTS was associated with the dimensions of depression, i.e.,
its affective, cognitive, and somatic dimension. LQTS mutation
carriers with a history of cardiac symptoms (especially those
with LQT1 – a subtype of LQTS being themost prevalent within
symptomatic LQTS men in our study sample and largely asso-
ciated with exercise-induced symptoms) are advised to avoid
strenuous physical activity (Priori et al. 2013). Consequently,
they could be physically less fit and thus experience greater
fatigue than others. The association between symptomatic
LQTS and depression could result mainly from tiredness related
to a poor physical condition or symptoms themselves, but the
present study showed that this is not the case. Symptomatic
LQTS was more strongly associated with the psychological
symptoms of depression, i.e., its affective and cognitive dimen-
sion, than with the somatic symptoms of depression.
The current results are in line with our previous findings
showing that symptomatic LQTS is associated with prolonged
mental stress (Hintsa et al. 2010) and a tendency to depressive
mood (Hintsa et al. 2009). The frequency of stressful life
events (i.e., death or illness of a family member, financial
difficulties, significant interpersonal conflicts, and mental
and physical assaults) has been reported to be higher in symp-
tomatic LQTS mutation carriers (Hintsa et al. 2010). Stressful
life events, in turn, have been shown to be associated with
increased emotional distress (Määttänen et al. 2013a) and de-
pressive symptoms in symptomatic LQTS mutation carriers
(Hintsa et al. 2016). Sex differences have not been detected in
these previous studies (Hintsa et al. 2009, 2010, 2016;
Määttänen et al. 2013a).
Potential Mechanisms
Sex differences in the self-concept (Cross and Madson 1997)
and stress responses (Stroud et al. 2002) may be mechanisms
underlying sex differences in depression. Men may tend to
construct and maintain their self-definition based on their
unique skills and pursuit of independence (independent self-
construal), whereas self-definition in women has been sug-
gested to be largely based on their social relationships and
pursuit of harmony (interdependent self-construal) (Cross
and Madson 1997). It has also been reported (Stroud et al.
2002) that men have greater physiological reactivity to
achievement stressors, while women are more reactive to so-
cial stressors. In view of this, symptomatic LQTS may have a
greater impact on mental health of men than women since the
disorder may limit major life activities and independence, and
inhibit habitual achievement strivings through periodic feel-
ings of exhaustion or the need to avoid activities that can
trigger arrhythmic events (Andersen et al. 2008). In particular,
cardiac symptoms can negatively affect working life of LQTS
patients, for example, due to the need to take a day off work or
being late (Andersen et al. 2008). This, in turn, together with
an increased cost of health care, may result in higher work
stress which has been shown to be more strongly associated
with depression in men than women (Shields 2006).
In addition to the fact that symptomatic LQTS may lead to
depression in men, depression may increase the risk of ar-
rhythmic events. It has been shown (Carney et al. 1993;
Watkins et al. 2006) that depression can enhance the likeli-
hood of ventricular arrhythmias in patients with coronary ar-
tery disease. Furthermore, depression has been linked to
prolonged mental stress (Hammen et al. 2009) that may com-
promise the physiological capacity to cope with stress
(Keltikangas-Jarvinen et al. 1996). This may be attributable
to the autonomic nervous system function since previous re-
search (Carney et al. 2002) has shown that depression is
Table 3 The results of binary logistic regression examining the association between lqts symptom status and depression
Group status Women(n = 256) Men(n = 113)
n OR (95 % CI) p-value R2 (%) n OR (95 % CI) p-value R2 (%)
Model 1 0.1 7.8
Asymptomatic LQTS 125 1.00 75 1.00
Symptomatic LQTS 131 1.01 (0.97, 1.04) .74 38 1.08 (1.01, 1.16) .024
Model 2 20.6 16.0
Asymptomatic LQTS 125 1.00 75 1.00
Symptomatic LQTS 131 0.99 (0.95, 1.03) .63 38 1.10 (1.03, 1.19) .009
Abbreviations: CI, confidence interval; n, number of participants; OR, odds ratio, R2 (Nagelkerke), fraction of explained variance
Reference group = asymptomatic LQTS
Model 1 unadjusted
Model 2 adjusted for age, β-blockers, antidepressants, and social support
Values of the coefficients in bold indicate statistical significance
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associated with an increased sympathetic and/or decreased
parasympathetic activity. This imbalance, in turn, has been
suggested to play an important role in the dynamic change
in the QT-interval and the initiation of torsade de pointes
(i.e., a specific form of ventricular tachycardia) in LQTS mu-
tation carriers (Fujiki et al. 2001). Human and non-human
animal research (Dart et al. 2002) has reported sex differences
in the function of the autonomic nervous system: males show-
ing a higher cardiac sympathetic responsiveness and females
showing a higher cardiac parasympathetic responsiveness.
Therefore, LQTS mutation carrier men may be at a higher risk
of arrhythmic events due to depression.
Physical inactivity may be another factor that could explain
the presence of the association between symptomatic LQTS
and depression in men and not in women in both directions.
LQTS mutation carriers with arrhythmic events have restric-
tions on their physical exercise (Priori et al. 2013), which has
been shown to protect against common mood and anxiety
states among men (Bhui and Fletcher 2000) and to prevent
inflammatory processes (Hamer et al. 2012). The latter, in
turn, has been suggested to induce depressive symptoms in
men but not in women (Elovainio et al. 2009). Conversely,
depression may result in exercise withdrawal (Roshanaei-
Moghaddam et al. 2009). Depressive symptoms, being partly
responsible for proinflammatory processes in men (Elovainio
et al. 2009), together with physical inactivity seem to interact
to increase cardiovascular mortality risk (Kamphuis
et al. 2007). Depression has also been associated with
a heightened expression of inflammation and coagula-
tion markers implicated in the pathogenesis of cardiac
disease (Panagiotakos et al. 2004).
Study Limitations and Research Recommendations
Some limitations of the study should be considered when
interpreting the results. First, as the study was cross-sectional,
it does not allow conclusions about the causality. Thus, it is
equally likely that symptomatic LQTS may lead to depression
in men or that depression may increase the risk of arrhythmic
events in LQTS mutation carrier men. A bidirectional associ-
ation that could proceed to a vicious cycle is also possible.
Second, depression was self-reported and defining depressive
disorder did not include a clinical diagnosis of depression. As
the analyzed data was based on self-report measures, some
reporting bias could arise. Self-reported depression is, howev-
er, unlikely to be severely affected by reporting bias because
we used BDI-II (Beck et al. 1996), a valid instrument to screen
for depressive disorder based on criteria from the DSM-IV.
Third, potential non-response to the BDI-II may also bias
the results. It is possible that those who did not respond were
either not able to do this due to feeling depressed or not inter-
ested in participating because they did not experience depres-
sion. Fourth, the self-reported arrhythmic events in LQTS
mutation carriers may include some that are not LQTS-type
ventricular arrhythmias, and the proportion of such is un-
known. Finally, the control group consisted of unaffected rel-
atives of LQTS mutation carriers who might not have been
validly comparable to the cases. There is the possibility that
they could feel worried about their family members having a
LQTS-causing mutation, experience guilt towards them be-
cause of not carrying the familial LQTS mutation (Bsurvivor
guilt^), and/or be stressed about caregiver responsibilities.
Our findings indicate that prospective studies are needed to
determine the direction of the association between symptom-
atic LQTS and depression. Mechanisms underlying this asso-
ciation are unclear, and thus warrant further research.
Furthermore, we suggest that future studies could benefit from
including clinically diagnosed depression and a population-
based control group. Also, examining whether an increase in
the severity of cardiac symptoms in LQTS mutation carriers is
associated with a higher risk of depression could be valuable.
Study Strengths and Practice Implications
The study has several strengths.We used a sample ofmolecularly
genotypedLQTSmutation carriers. Furthermore, we used a valid
measure of depression which is meant to screen for depressive
disorder.Wewere also able to consider dimensions of depression
and several potential confounders, such as targeted medications
for LQTS and depression, social support, and education, all of
which are important when studying depression.
Our results indicate that it may be important to focus on
preventive care and treatment of depression as an integral com-
ponent of practice in the health care of all LQTS mutation
carriers and their unaffected relatives. We recommend that pri-
mary health-care professionals, cardiologists, and genetic coun-
selors should be trained in routine checking for depression in
people carrying a LQTS-causing mutation and in the manage-
ment of those who screened positively for depression (e.g.,
referring the patients to mental health specialists). Therefore,
informing this group of patients of the importance of attending
regular physical and mental health checks, and encouraging
them to report any negative mood changes can be important.
Genetic counseling has been described as a time-limited,
highly circumscribed form of psychotherapy in which effec-
tive communication of genetic information is the main thera-
peutic goal (Austin et al. 2014). Individuals with hypertrophic
cardiomyopathy (i.e., a heritable condition associated with an
increased risk of sudden cardiac death) who attend specialized
cardiac genetic clinics, providing genetic counseling, have
shown to be better adjusted, less worried, and less depressed
compared with those who do not (Ingles et al. 2008). Also,
LQTS mutation patients have described their contact with a
genetic counselor as a positive experience (Andersen et al.
2008). Given this, we suggest that offering genetic counseling
can be beneficial for prevention and treatment of depression in
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LQTS mutation carriers and their family members. The inclu-
sion of career counseling in people affected with LQTS-
causing mutation could also be of value.
Conclusions
We found that being diagnosed as a LQTS mutation carrier is
not associated with depression. In men, symptomatic LQTS is
associated with an increased risk of depression and its affec-
tive, cognitive, and somatic dimension independently of age,
selected medication (β-blockers and antidepressants), social
support, and education. More women than men experience
arrhythmic events. Also, women score higher on depression
and all its dimensions compared with men, and a greater num-
ber of women than men screen positively for depressive dis-
order. The general tendency of women to report more depres-
sive symptoms compared with men might account for their
higher levels of depression and greater likelihood of meeting
criteria for depressive disorder (Piccinelli and Wilkinson
2000). However, symptomatic LQTS is not associated with
depression in women. Together, these findings suggest that
regular screening for depression in all LQTS mutation carriers
and their unaffected family members can be important.
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